Thank you for subscribing!
Finfeed Archived Feb 15, 2021
Following the successful in vitro findings, Neurotech (ASX: NTI) has begun designing a phase I/II study to assess the safety and efficacy of the novel NTI/Dolce strain in a paediatric population.
Finfeed Archived Feb 01, 2021
Creso Pharma (ASX: CPH) is prepared to meet demand as OTC sales of low-dose cannabidiol products start in Australian pharmacies.
Finfeed Archived Dec 15, 2020
Creso Pharma (ASX: CPH) is positioned to significantly benefit from a TGA decision to down-schedule low dose CBD preparations.
Finfeed Archived Dec 11, 2020
Creso Pharma Limited (ASX:CPH, FRA:1X8) has today announced obtainment of an exclusive Heads of Agreement with leading natural, sustainable health and lifestyle brand supplier Martin & Pleasance Pty Ltd.
Get expert stock analysis direct in your inbox
Finfeed Archived Dec 02, 2020
Creso Pharma (ASX: CPH) has received three new purchase orders totalling $414,000 for its anibidiol® line of animal health products.
Finfeed Archived Nov 26, 2020
The Therapeutic Goods Administration (TGA) will shortly bring down its final decision regarding a major regulatory change in the distribution of cannabidiol (CBD) products in Australia, which could hellp stocks such as Creso Pharma (ASX: CPH).
Finfeed Archived Sep 10, 2020
The TGA has recommended that CBD products be down-scheduled to schedule 3 medicines in Australia, allowing OTC sales, which should benefit Creso Pharma (ASX: CPH).
Finfeed Archived Jun 22, 2020
BPH Energy (ASX:BPH) investee Cortical Dynamics has applied for FDA approval for its BARM brain monitoring technology.
Finfeed Archived May 05, 2020
G Medical receives Therapeutics Goods Administration (TGA) approval for its G Medical Extended Holter Patch (GMP)
Finfeed Archived Apr 16, 2020
Due to COVID-19 challenges, Allegra Orthopaedics Limited (ASX: AMT) has commenced distribution of high-quality face shields which are Australian designed and manufactured.
Join Our Mailing List
